Analyst Call - rescheduled
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Torrent Pharmaceuticals has rescheduled its post-quarterly financial result conference call with investors and analysts. The call to discuss Q4 and full-year performance ending 31 March 2026 has been moved from 06:30 PM to 05:30 PM on 22 May 2026. The dial-in details and conference access information remain unchanged from the original notice dated 12 May 2026. The company sent this update via email on 16 May 2026, providing approximately one week's notice to the exchanges and market participants.
No material impact on the stock. This is a routine scheduling adjustment with no change to the event's substance or participation details.